Salinomycin inhibits breast cancer progression via targeting HIF-1 alpha/VEGF mediated tumor angiogenesis in vitro and in vivo

Dewangan, J; Srivastava, S; Mishra, S; Divakar, A; Kumar, S; Rath, SK

Rath, SK (reprint author), CSIR Cent Drug Res Inst, Div Toxicol & Expt Med, Genotox Lab, Lucknow 226031, Uttar Pradesh, India.

BIOCHEMICAL PHARMACOLOGY, 2019; 164 (): 326